Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
Alkali-Burn Wound Healing, VEGF-A & ERK1/2 (PMC / Dove Press, 2015) A controlled study published in PMC and Dove Press investigated BPC-157s effects on alkali-burn wound healing in vivo and on HUVEC (human umbilical vein endothelial cell) behaviour in vitro
Increasing evidence (Weiland et al., 2019) indicates that ferroptosis may be a driver in some CNS diseases caused by the dysfunction and cell death in CNS, such as stroke, Parkinson's disease (PD), Alzheimer's disease (AD), and Huntington's disease (HD)
Trust the process and continue consistent application
)
Technical Specifications Compound: Glycyl-L-Histidyl-L-Lysine Copper Complex (GHK-Cu) Format: Lyophilized peptide powder Strength: 50 mg per vial Purity: 9899% (COA included) Appearance: Blue-tinted lyophilized powder Category: Research peptide reagent Intended Use This product is intended solely for: Laboratory experimentation Controlled in-vitro research Molecular and biochemical pathway studies Metal-peptide interaction research Non-human preclinical modeling Academic and institutional scientific projects Not intended for: Human or animal consumption Injection, ingestion, inhalation, topical, or cosmetic use Medical, therapeutic, or dermatological applications This material is not approved by Health Canada, FDA, or any regulatory body for clinical or cosmetic use
10.1074/jbc.M109117200
US$ 27.74
US$ 29.03
US$ 22.66
US$ 23.28
US$ 21.32
